Biopharmaceutical Informatics
Biopharmaceutical informatics combines a knowledge-based informatics approach (database creation, curation, mining, etc.) with physics-based molecular modeling and simulation tools (derived from computational biophysics) for biopharmaceuticals. It is an interdisciplinary field that supports the development of. As with many new areas of science and technology, it is too early to provide an accurate definition of biopharmaceutical informatics. Biopharmacy informatics is a computational task, either alone or in combination with experimental studies, aimed at facilitating efficient and cost-effective translation of biopharmacy candidates into drugs. This article describes calculations focused on predicting the site of chemical degradation of biopharmaceutical candidates. In particular, case studies will be used to discuss those involved in methionine oxidation, lysine saccharification, asparagine deamidation, and aspartic acid isomerization. However, computational modeling applications extend to assessing other aspects of the feasibility of biological agents, such as the development of biological agents (see the various chapters of Kumar and Singh's Book 4). These techniques can be extended to late product development and lifecycle management of biopharmaceuticals already on the market. Business development is another potential application of biopharmacy informatics, enabling feasibility risk assessments to be integrated into the decision-making process for introducing biopharmaceutical candidates for development. Therefore, biopharmacy informatics can be applied organically at all stages of biopharmaceutical discovery and development whenever knowledge of molecular properties is required.
Related Conference of Biopharmaceutical Informatics
4th International Conference on Biomedicine & Pharmacotherapy
Biopharmaceutical Informatics Conference Speakers
Recommended Sessions
- Advanced Drug Delivery System
- BCS and IVIVC Based Biowaivers
- Biological Medicine
- Biopharmaceutical Informatics
- Chemical and Analytical Strategies for Biosimilars
- Consequences of Brexit on Biosimilars
- Digital Pharma
- Drug Delivery Technology
- Drug Formulation
- Encapsulated Drugs
- Intellectual Property Rights
- Pharmaceutical Chemistry
- Pharmaceutical Manufacturing
- Pharmacogenomics
Related Journals
Are you interested in
- Advanced Pharmaceutical Technology - Pharma Conference 2024 (UAE)
- Bioequivalence and Bioavailability - Pharma Conference 2024 (UAE)
- Clinical Pharmacy and Pharmacy Practices - Pharma Conference 2024 (UAE)
- Digital Pharma and Marketing - Pharma Conference 2024 (UAE)
- Drug Discovery - Pharma Conference 2024 (UAE)
- Drug Discovery - Pharma Conference 2024 (UAE)
- Drug Discovery, Design & Development: Challenges and Approaches - Pharma Conference 2024 (UAE)
- Nano medicine and Biomedical Application - Pharma Conference 2024 (UAE)
- Novel Drug Delivery Systems, Biomarkers and Drug Targets - Pharma Conference 2024 (UAE)
- Pharmaceutical Analysis - Pharma Conference 2024 (UAE)
- Pharmaceutical Care and Health System - Pharma Conference 2024 (UAE)
- Pharmaceutical Innovation - Pharma Conference 2024 (UAE)
- Pharmaceutical Innovation - Pharma Conference 2024 (UAE)
- Pharmaceutical Innovation - Pharma Conference 2024 (UAE)
- Pharmaceutical manufacturing and Pharmacoeconomics - Pharma Conference 2024 (UAE)
- Pharmaceutical Microbiology - Pharma Conference 2024 (UAE)
- Pharmaceutical Nanotechnology - Pharma Conference 2024 (UAE)
- Pharmacogenomics and Pharmacoepidemiology - Pharma Conference 2024 (UAE)
- Pharmacology and Toxicology - Pharma Conference 2024 (UAE)
- Technology in Pharma Sciences - Pharma Conference 2024 (UAE)
- The future of Pharma R&D - Pharma Conference 2024 (UAE)